Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
Charles River Laboratories (NYSE: CRL) has announced it will release its fourth-quarter and full-year 2024 financial results along with 2025 guidance on Wednesday, February 19th, before market opening. The company has scheduled a conference call at 8:30 a.m. ET on the same day to discuss these results.
Investors can access a live webcast of the conference call through the Investor Relations section of the company's website at ir.criver.com. A replay of the call will also be made available through the same platform.
Charles River Laboratories (NYSE: CRL) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 insieme alle previsioni per il 2025 mercoledì 19 febbraio, prima dell'apertura del mercato. L'azienda ha programmato una conferenza telefonica per le 8:30 a.m. ET lo stesso giorno per discutere di questi risultati.
Gli investitori possono accedere a una diretta della conferenza telefonica attraverso la sezione Relazioni con gli Investitori del sito web dell'azienda all'indirizzo ir.criver.com. Una registrazione della chiamata sarà disponibile anche attraverso la stessa piattaforma.
Charles River Laboratories (NYSE: CRL) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 junto con la guía para 2025 el miércoles 19 de febrero, antes de la apertura del mercado. La compañía ha programado una conferencia telefónica a las 8:30 a.m. ET el mismo día para discutir estos resultados.
Los inversores pueden acceder a una transmisión en vivo de la conferencia telefónica a través de la sección de Relaciones con Inversores del sitio web de la compañía en ir.criver.com. También se pondrá a disposición una grabación de la llamada a través de la misma plataforma.
찰스 리버 연구소 (NYSE: CRL)는 2024년 4분기 및 연간 재무 결과와 2025년 가이드라인을 시장 개장 전에 2월 19일 수요일에 발표한다고 발표했습니다. 회사는 같은 날 오전 8시 30분 ET에 이러한 결과를 논의하기 위한 전화 회의를 예정했습니다.
투자자들은 회사 웹사이트의 투자자 관계 섹션 ir.criver.com을 통해 전화 회의의 실시간 웹캐스트에 접근할 수 있습니다. 또한 동일한 플랫폼을 통해 통화 재생도 제공될 예정입니다.
Charles River Laboratories (NYSE: CRL) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'année complète 2024 ainsi que les prévisions pour 2025 le mercredi 19 février, avant l'ouverture du marché. L'entreprise a prévu une conférence téléphonique le même jour à 8h30 ET pour discuter de ces résultats.
Les investisseurs peuvent accéder à un webinaire en direct de la conférence téléphonique via la section Relations Investisseurs du site web de l'entreprise à l'adresse ir.criver.com. Un replay de l'appel sera également disponible via la même plateforme.
Charles River Laboratories (NYSE: CRL) hat angekündigt, dass es am Mittwoch, den 19. Februar, vor Markteröffnung seine Finanzergebnisse für das vierte Quartal und das gesamte Geschäftsjahr 2024 sowie die Prognose für 2025 veröffentlichen wird. Das Unternehmen hat für den selben Tag um 8:30 Uhr ET eine Telefonkonferenz angesetzt, um diese Ergebnisse zu besprechen.
Investoren können über den Bereich Investorenbeziehungen auf der Website des Unternehmens unter ir.criver.com auf einen Live-Webcast der Telefonkonferenz zugreifen. Eine Wiederholung des Anrufs wird ebenfalls über dieselbe Plattform bereitgestellt.
- None.
- None.
Investors will have the opportunity to listen to a live webcast of the conference call through the Investor Relations section of the Company's website at ir.criver.com. A replay will be accessible through the same website.
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128064004/en/
Investor Relations:
Todd Spencer
Corporate Vice President, Investor Relations
781.222.6455
todd.spencer@crl.com
Source: Charles River Laboratories International, Inc.
FAQ
When will Charles River Labs (CRL) release Q4 2024 earnings?
When is Charles River Labs (CRL) providing 2025 guidance?
What time is Charles River Labs (CRL) Q4 2024 earnings call?
How can investors access Charles River Labs (CRL) Q4 2024 earnings call?
